17,261 trials
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
Primary: P2Y12 Reaction Units (PRU) - Part A — 301.6; 268.0; 295.4; 287.7 P2Y12 reaction units
Acute Myelogenous Leukemia · High-Grade Myelodysplastic Syndrome
Primary: Best Overall Response Rate (ORR) Based on Investigator's Assessment — 6; 0; 1; 0 participants
Biliary Atresia
Primary: Feasibility of IVIG Treatment — 23 Participants
Respiratory Syncytial Virus Infection
Primary: Time-weighted Average Change in Nasal Respiratory Syncytial Viral (RSV) Load From Baseline to Day 9 — -1.00; -0.97 log10 copies/mL — p=0.94
Cardiac Output
Primary: Change in Cardiac Output From Baseline to 20 Minutes Post-spinal — -2.05; -1.92 L/min
Schizophrenia · Schizoaffective Disorder
Primary: PANSS Positive and Negative Syndrome Scale for Schizophrenia — 70.08; 83.92; 72.25; 77 Scores on the scale
Advanced Breast Cancer · Advanced Malignant Solid Tumors · Breast Neoplasms
Primary: Dose Limiting Toxicity Incidence of Neratinib in Combination With Paclitaxel — 0; 0 Participants
Chronic Obstructive Pulmonary Disease
Primary: Safety Profile of Oral Cyclosporin A Immunotherapy in Advanced Stage Chronic Obstructive Pulmonary Disease Patients- Nephrotoxicity - Measured by Serum Creatinine…
Prostate Cancer
Primary: Percentage of Participants With Effective Castration Rate Over 24 Weeks — 91; 91; 96 percentage of participants
Hodgkin's Disease
Primary: Transplant Related Mortality Rate — 1; 6 Participants
Breast Cancer · Advanced Malignant Solid Tumors
Primary: Overall Response Rate — 35.9; 13.3 percentage of participants
Esophageal Cancer · Gastric Cancer
Primary: 6-month Progression-free Survival (PFS) — 60.5; 57.1 percent probability — p=0.72
Osteoporosis
Primary: Change in Spine Bone Density From Baseline to 2 Years — 8.3; 9.5; 12.9 percent change
Cocaine-Related Disorders
Primary: Urine Toxicology for Cocaine — 3; 8; 3 Participants
Metastatic Pancreatic Cancer
Primary: Overall Survival (OS) in Subjects Receiving Test Treatments (FAS) — 6.28; 4.07 months